126 related articles for article (PubMed ID: 11733228)
1. An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.
Zhang R; DeGroot LJ
Endocr Relat Cancer; 2001 Dec; 8(4):315-25. PubMed ID: 11733228
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy.
Zhang R; DeGroot LJ
Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059
[TBL] [Abstract][Full Text] [Related]
3. Treatment of medullary thyroid carcinoma by combined expression of suicide and interleukin-2 genes.
Soler MN; Milhaud G; Lekmine F; Treilhou-Lahille F; Klatzmann D; Lausson S
Cancer Immunol Immunother; 1999; 48(2-3):91-9. PubMed ID: 10414462
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
Minemura K; Takeda T; Minemura K; Nagasawa T; Zhang R; Leopardi R; DeGroot LJ
Endocrinology; 2000 May; 141(5):1814-22. PubMed ID: 10803592
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Zhang R; Straus FH; DeGroot LJ
Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2.
Zhang R; Minemura K; De Groot LJ
Endocrinology; 1998 Feb; 139(2):601-8. PubMed ID: 9449631
[TBL] [Abstract][Full Text] [Related]
9. Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model.
Zhang R; DeGroot LJ
Clin Endocrinol (Oxf); 2000 Jun; 52(6):687-94. PubMed ID: 10848872
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.
Yamazaki M; Straus FH; Messina M; Robinson BG; Takeda T; Hashizume K; DeGroot LJ
Cancer Gene Ther; 2004 Jan; 11(1):8-15. PubMed ID: 14681722
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific viral gene therapy of a Hurthle cell tumor.
Zhang R; Straus FH; DeGroot LJ
J Clin Endocrinol Metab; 2002 Mar; 87(3):1407-14. PubMed ID: 11889217
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
14. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
15. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
16. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.
Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Franchin E; Del Vecchio C; Giaretta I; Boscaro M; Palù G
Eur J Endocrinol; 2003 Jan; 148(1):73-80. PubMed ID: 12534360
[TBL] [Abstract][Full Text] [Related]
18. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
[TBL] [Abstract][Full Text] [Related]
19. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
